Additional file 5 of Splicing targeting drugs highlight intron retention as an actionable vulnerability in advanced prostate cancer
dataset
posted on 2024-08-14, 23:49 authored by Chiara Naro, Ambra Antonioni, Vanessa Medici, Cinzia Caggiano, Ariane Jolly, Pierre de la Grange, Pamela Bielli, Maria Paola Paronetto, Claudio SetteAdditional file 5: Supplementary Table S10. List of annotated splicing events regulated by Pladienolide B, Indisulam and THZ531 in 22Rv1 cells compared to control (fold change >=2, p-value<=0.05).
